Skip to content
AwardedSpainGoods

Suministro del principio activo denominado "Crovalimab 340mg/2ml vial intravenosa/subcutanea" para el Hospital Universitario de Gran Canaria Dr. Negrín.

Published
Published 20 March 2026

Overview

El objeto del contrato viene determinado por el suministro del principio activo denominado "CROVALIMAB 340MG/2 MLVIAL INTRAVENOSA/SUBCUTANEA" para el Hospital Universitario de Gran Canaria Dr. Negrín. Dicho objeto corresponde al código 33690000-3 (Medicamentos diversos), de la nomenclatura Vocabulario Común de Contratos (CPV) de la Comisión Europea.

Key details

Country
Spain
Status
Awarded
Category
Goods
Procedure
Direct
Published
20 March 2026
Classification (CPV)
Various medicinal products

Award outcome

Awarded value
€271,130
Award date
8 February 2026
Winner
  • Roche Farma, S.A.

Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.

Notice history

Every published notice in this contracting process, newest first.

  1. Contract Award Notice

    20 March 2026

Contracting authority

  • Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín

    Procuring entity

    Las Palmas de Gran Canaria, Spain

    ID_PLATAFORMA: 21050930148853

    Authority website ↗

Get the full picture

AI analysis, bid scoring, and expert strategy for this tender

Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.

See which competitors are winning the contracts you're chasing.

15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.

Awarded: Suministro del principio activo denominado "Crovalimab 340mg/2ml vial intravenosa/subcutanea" para el Hospital Universitario de Gran Canaria Dr. Negrín. — won by Roche Farma, S.A. — Skim